Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors (2004)
Subjects: GENES SUPRESSORES DE TUMOR, EXPRESSÃO GÊNICA
ABNT
COSTA, Fabrício F. et al. Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors. Oncogene, v. 23, n. 7, p. 1481-1488, 2004Tradução . . Disponível em: https://doi.org/10.1038/sj.onc.1207263. Acesso em: 30 set. 2024.APA
Costa, F. F., Verbisck, N. V., Salim, A. C. de M., Ierardi, D. F., Pires, L. C. P., Sasahara, R. M., et al. (2004). Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors. Oncogene, 23( 7), 1481-1488. doi:10.1038/sj.onc.1207263NLM
Costa FF, Verbisck NV, Salim AC de M, Ierardi DF, Pires LCP, Sasahara RM, Sogayar MC, Zanata SM, Mackay A, O'Hare M, Soares FA, Simpson AJG, Camargo AA. Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors [Internet]. Oncogene. 2004 ; 23( 7): 1481-1488.[citado 2024 set. 30 ] Available from: https://doi.org/10.1038/sj.onc.1207263Vancouver
Costa FF, Verbisck NV, Salim AC de M, Ierardi DF, Pires LCP, Sasahara RM, Sogayar MC, Zanata SM, Mackay A, O'Hare M, Soares FA, Simpson AJG, Camargo AA. Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors [Internet]. Oncogene. 2004 ; 23( 7): 1481-1488.[citado 2024 set. 30 ] Available from: https://doi.org/10.1038/sj.onc.1207263